LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,194 Cr | ₹793 Cr | ₹723 Cr | ₹1,029 Cr | ₹664 Cr |
What is the latest Net Current Assets ratio of LAURUS LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,194 Cr |
| Mar2025 | ₹793 Cr |
| Mar2024 | ₹723 Cr |
| Mar2023 | ₹1,029 Cr |
| Mar2022 | ₹664 Cr |
How is Net Current Assets of LAURUS LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,194 Cr | 50.62 | |
| Mar2025 | ₹793 Cr | 9.67 | |
| Mar2024 | ₹723 Cr | -29.80 | |
| Mar2023 | ₹1,029 Cr | 55.13 | |
| Mar2022 | ₹664 Cr | - | |
Compare Net Current Assets of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹105,642.2 Cr | -0.8% | 8.2% | 118.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -0.8% |
8.2% |
118.4% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses